Cumberland Pharmaceuticals (CPIX) Profit After Tax (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Profit After Tax of -$3.3 million for Q1 2026, down 130.26% sequentially from -$1.4 million in Q4 2025, and down 361.69% YoY from $1.3 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Profit After Tax (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Profit After Tax for 17 years, with the latest figure at -$3.3 million in Q1 2026.
- Quarterly Profit After Tax fell 361.69% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.4 million (down 126.74% YoY) and the FY2025 annual result came in at -$2.8 million, up 56.23% from the prior year.
- Profit After Tax fell to -$3.3 million in Q1 2026 per CPIX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Profit After Tax peaked at $1.3 million in Q1 2025 and troughed at -$6.3 million in Q4 2023.
- A 5-year average of -$1.4 million and a median of -$1.4 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax plunged 1204.25% in 2024, then jumped 166.08% in 2025.
- Over 5 years, Profit After Tax stood at -$2.4 million in 2022, then plunged by 158.2% to -$6.3 million in 2023, then soared by 69.82% to -$1.9 million in 2024, then gained by 24.87% to -$1.4 million in 2025, then sank by 130.26% to -$3.3 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$3.3 million, -$1.4 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.16 Mn | 110.30 Mn | - | -4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.28 Mn |
| Mar 31, 2026 | -3.29 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -740,740.00 |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | -1.90 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | -6.30 Mn |
| Sep 30, 2023 | -1.05 Mn |
| Jun 30, 2023 | 872,200.00 |
| Mar 31, 2023 | 172,286.00 |
| Dec 31, 2022 | -2.44 Mn |
| Sep 30, 2022 | -423,226.00 |
| Jun 30, 2022 | -1.36 Mn |
| Mar 31, 2022 | -1.40 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -1.06 Mn |